Nan Zhou

3.3k total citations · 1 hit paper
73 papers, 2.4k citations indexed

About

Nan Zhou is a scholar working on Accounting, Finance and Economics and Econometrics. According to data from OpenAlex, Nan Zhou has authored 73 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Accounting, 14 papers in Finance and 12 papers in Economics and Econometrics. Recurrent topics in Nan Zhou's work include Auditing, Earnings Management, Governance (37 papers), Corporate Finance and Governance (29 papers) and Financial Markets and Investment Strategies (11 papers). Nan Zhou is often cited by papers focused on Auditing, Earnings Management, Governance (37 papers), Corporate Finance and Governance (29 papers) and Financial Markets and Investment Strategies (11 papers). Nan Zhou collaborates with scholars based in United States, China and Hong Kong. Nan Zhou's co-authors include Jian Zhou, Yan Zhang, Re‐Jin Guo, Baruch Lev, Zhilin Yang, Shaohan Cai, S. Krishnamurthy, Jun Guo, Pinghsun Huang and Dong Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Ophthalmology.

In The Last Decade

Nan Zhou

64 papers receiving 2.2k citations

Hit Papers

Audit committee quality, auditor independence, and intern... 2007 2026 2013 2019 2007 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nan Zhou United States 19 1.6k 710 373 292 248 73 2.4k
Hervé Stolowy France 25 2.4k 1.5× 1.7k 2.4× 442 1.2× 234 0.8× 202 0.8× 87 3.2k
Philip Shrives United Kingdom 20 2.2k 1.4× 1.8k 2.6× 417 1.1× 274 0.9× 170 0.7× 34 3.3k
Mingfang Li United States 22 848 0.5× 1.1k 1.5× 142 0.4× 415 1.4× 128 0.5× 44 2.0k
Reggy Hooghiemstra Netherlands 20 1.0k 0.6× 1.1k 1.5× 132 0.4× 142 0.5× 177 0.7× 42 1.9k
Claire Marston United Kingdom 19 2.0k 1.2× 1.3k 1.8× 371 1.0× 134 0.5× 123 0.5× 39 2.6k
Stuart Locke New Zealand 22 1.5k 0.9× 557 0.8× 260 0.7× 586 2.0× 204 0.8× 96 2.1k
Dasaratha V. Rama United States 30 3.6k 2.2× 1.3k 1.8× 595 1.6× 249 0.9× 163 0.7× 70 4.0k
Hichem Khlif Tunisia 24 1.6k 1.0× 1.0k 1.4× 168 0.5× 341 1.2× 155 0.6× 51 2.1k
Rani Hoitash United States 27 2.9k 1.8× 1.2k 1.7× 589 1.6× 369 1.3× 119 0.5× 78 3.3k
R. S. Olusegun Wallace United Kingdom 14 1.8k 1.1× 1.1k 1.6× 289 0.8× 143 0.5× 111 0.4× 25 2.3k

Countries citing papers authored by Nan Zhou

Since Specialization
Citations

This map shows the geographic impact of Nan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Zhou more than expected).

Fields of papers citing papers by Nan Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Zhou. The network helps show where Nan Zhou may publish in the future.

Co-authorship network of co-authors of Nan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Nan Zhou. A scholar is included among the top collaborators of Nan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Zhou. Nan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhou, Nan, Yuan Yuan, Jian Wang, et al.. (2025). Epigallocatechin Gallate InducesmiR-192/215Suppression ofEGR1in Gastric Cancer. Anticancer Research. 45(5). 1935–1951.
3.
Tian, Ping, et al.. (2024). Lentinan mitigates pemetrexed chemoresistance by the PI3K/Akt pathway in non-small cell lung cancer. Cell Biochemistry and Biophysics. 82(2). 1421–1431. 6 indexed citations
4.
Zhou, Nan, et al.. (2024). Swept-Source OCT Angiography of Presumed Optic Nerve Metastasis from Breast Carcinoma. Ophthalmology. 132(4). e74–e74.
5.
Shi, Linna, et al.. (2024). Audit Partner Characteristics and Their Impacts on Audit Quality: Evidence from around the World. SHILAP Revista de lepidopterología. 4(3). 1091–1099.
6.
Shi, Linna, et al.. (2024). Director Interlocks: Information Transfer in Board Networks. SHILAP Revista de lepidopterología. 4(1). 117–124. 1 indexed citations
7.
Chen, Hanwen, Siyi Liu, Daoguang Yang, & Nan Zhou. (2024). COSO-Based Internal Control and Accounts Receivable Management. Journal of International Accounting Research. 24(2). 131–154. 1 indexed citations
8.
Zhou, Nan, et al.. (2023). How sustainable business model innovation and green technology innovation interact to affect sustainable corporate performance. Frontiers in Environmental Science. 11. 13 indexed citations
9.
Zhou, Nan, et al.. (2023). The value of ultrasound combined with CT in identifying early low-grade appendiceal mucinous neoplasm and appendicitis. Frontiers in Oncology. 13. 1191785–1191785. 1 indexed citations
10.
Yin, Kun, et al.. (2022). The characteristics of thoracic aortic dissection in autopsy-diagnosed individuals: An autopsy study. Frontiers in Cardiovascular Medicine. 9. 973530–973530. 5 indexed citations
11.
Zhou, Nan, et al.. (2022). Radiomics analysis based on CT’s greater omental caking for predicting pathological grading of pseudomyxoma peritonei. Scientific Reports. 12(1). 4401–4401. 2 indexed citations
12.
Zhang, Qian, et al.. (2022). Combined ultrasonography and CT for prognosis and predicting clinical outcomes of patients with pseudomyxoma peritonei. European Radiology. 33(4). 2800–2808. 2 indexed citations
13.
Zhou, Nan, et al.. (2021). Pseudomyxoma peritonei originating from intestinal duplication: A case report and review of the literature. World Journal of Clinical Cases. 9(25). 7459–7467. 3 indexed citations
14.
Wang, Wenhai, et al.. (2019). Value of preoperative ultrasound in evaluating the peritoneal cancer index of pseudomyxoma peritonei. World Journal of Surgical Oncology. 17(1). 192–192. 5 indexed citations
15.
Zhang, Yan & Nan Zhou. (2018). The Mitigating Effect of Audit Committee Financial Expertise on the Voluntary Adoption of Clawback Policies. RePEc: Research Papers in Economics. 3(1). 85–114. 3 indexed citations
16.
Zhou, Nan, et al.. (2017). Urachal mucinous adenocarcinoma with pseudomyxoma peritonei. Medicine. 96(35). e7548–e7548. 10 indexed citations
17.
Zhou, Nan. (2012). Recent Advances in the Application of Near-Infrared Spectroscopy in Beef Quality Grading Systems.
18.
Zhou, Luyao, et al.. (2012). Value of three‐dimensional hysterosalpingo‐contrast sonography with SonoVue in the assessment of tubal patency. Ultrasound in Obstetrics and Gynecology. 40(1). 93–98. 55 indexed citations
19.
Xu, Lan, Fuan Li, Nan Zhou, Zhilin Yang, & Paul W. Miniard. (2011). Integrity and Benevolence: an Examination of Their Distinct Roles in Building Consumer Trust. ACR Asia-Pacific Advances. 1 indexed citations
20.
Krishnamurthy, S., Jian Zhou, & Nan Zhou. (2005). Auditor Reputation, Auditor Independence, and the Stock-Market Impact of Andersen's Indictment on Its Client Firms. SSRN Electronic Journal. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026